Harvard Bioscience HBIO

February 10, 2014 - 1:33pm EST by

member

						2014	2015
Price:		4.30		EPS		$0.00	$0.25
Shares Out. (in M):		31		P/E		0.0x	17.0x
Market Cap (in $M):		132		P/FCF		0.0x	13.0x
Net Debt (in $M):		5		EBIT		0	11
TEV (in $M):		137		TEV/EBIT		0.0x	12.0x

Description

Sign up or Log In

Sign up for free guest access to view investment ideas with a 45-day delay and read the full report.

Log in to read the full report.

show sort by

You are not eligible to view 13 messages. To gain access to more recent message posts signup free for membership.

19	member 1/15/09 10:47AM RE: RE: RE: gi03's questions 18
By under writing margins, do you mean 95% MLR, in which case the profit is really just overhead absorbtion since on an operating margin basis, after expenses, MA would be unprofitable? Thanks. view available tags
13	member 1/12/09 4:24PM statutory capital 12
Curious if you share the math behind the $6 excess capital at statutory subsidaries? thank you. view available tags
12	member 1/12/09 1:32PM RE: RE: RE: RE: RE: RE: MLR 11
as well as your estimate that LCA's MLR is 85%? view available tags
11	member 1/12/09 1:28PM RE: RE: RE: RE: RE: MLR 10
curious how you arrive at your $20m purchase price estimate for LCA? view available tags
6	member 1/08/09 2:54PM Question
Thanks for this idea. Can you expand on why GTS should be acquired by WLP? Because this is a basically local business, it's not clear to me what the leverage is in adding lives in... login to read the rest view available tags
1	member 12/31/08 4:25PM Puerto Rico and healthcare cha
nice idea and nice write up. I would appreciate your thoughts on the following: 1.) What is competition like in Puerto Rico 2.) What is worst case scenario for possible downside risks from healthcare reform for view available tags

load more messages